NPTX2 hypermethylation in pure pancreatic juice predicts pancreatic neoplasms

American Journal of the Medical Sciences

Volumn 346, Issue 3, 2013, Pages 175-180

  Yao, Fan ^a   Sun, Mingjun ^a   Dong, Ming ^a   Jing, Feng ^a   Chen, Bo ^a   Xu, Huimian ^a   Wang, Shubao ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Methylation; Neuronal pentraxin II (NPTX2); Pancreatic cancer; Pancreatic neoplasms

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CHRONIC PANCREATITIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE COURSE; DNA METHYLATION; FEMALE; GENE; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MAJOR CLINICAL STUDY; MALE; NPTX2 GENE; PANCREAS CANCER; PANCREAS JUICE; PANCREAS TUMOR; PROMOTER REGION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

EID: 84883740966     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e31827b94b6     Document Type: Article

References (33)

1. Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277-300.
2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58 71-96. (Pubitemid 351521864)
3. Lowenfels AB, Maisonneuve P. Epidemiology and prevention of PCa. Jpn J Clin Oncol. 2004;34:238-44.
4. Sahmoun AE, D'Agostino RA Jr, Bell RA, et al. International variation in PCa mortality for the period 1955-1998. Eur J Epidemiol. 2003;18:801-16. (Pubitemid 37039979)
5. Sakorafas GH, Tsiotou AG. Multi-step pancreatic carcinogenesis and its clinical implications. Eur J Surg Oncol. 1999;25:562-5.
6. Moore PS, Sipos B, Orlandini S, et al. Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4. Virchows Arch. 2001;439:798-802. (Pubitemid 33141325)
7. Watanabe H, Ha A, Hu YX, et al. K-ras mutations in duodenal aspirate without secretin stimulation for screening of pancreatic and biliary tract carcinoma. Cancer. 1999;86:1441-8. (Pubitemid 29489776)
8. Yamaguchi Y, Watanabe H, Yrdiran S, et al. Detection of mutations of p53 tumor suppressor gene in pancreatic juice and its application to diagnosis of patients with PCa: comparison with K-ras mutation. Clin Cancer Res. 1999;5:1147-53. (Pubitemid 29233231)
9. Kuroki T, Trapasso F, Yendamuri S, et al. Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res. 2003;63:3724-28. (Pubitemid 36793058)
10. Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet. 1999;21:163-7. (Pubitemid 29070360)
11. Kuroki T, Trapasso F, Yendamuri S, et al. Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in nonsmall cell lung cancer. Cancer Res. 2003;63:3352-5. (Pubitemid 36735894)
12. Kuroki T, Trapasso F, Yendamuri S, et al. Promoter hypermethylation of RASSF1A in esophageal squamous cell carcinoma. Clin Cancer Res. 2003;9:1441-5. (Pubitemid 36418399)
13. Esteller M, Herman JG. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol. 2002;196:1-7.
14. Esteller M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene. 2002;21:5427-40. (Pubitemid 34983479)
15. Fukushima N, Sato N, Ueki T, et al. Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma. Am J Pathol. 2002;160:1573-81. (Pubitemid 34525637)
16. Dammann R, Schagdarsurengin U, Liu L, et al. Frequent RASSF1A promoter hypermethylation and K-ras mutations in pancreatic carcinoma. Oncogene. 2003;22:3806-12. (Pubitemid 36760743)
17. Miyamoto K, Asada K, Fukutomi T, et al. Methylation-associated silencing of heparan sulfate D-glucosaminyl 3-O-sulfotransferase-2 (3-OST-2) in human breast, colon, lung and PCas. Oncogene. 2003;22:274-80. (Pubitemid 36174184)
18. Matsubayashi H, Sato N, Fukushima N, et al. Methylation of cyclin D2 is observed frequently in PCa but is also an age-related phenomenon in gastrointestinal tissues. Clin Cancer Res. 2003;9:1446-52. (Pubitemid 36418400)
19. Fukushima N, Sato N, Sahin F, et al. Aberrant methylation of suppressor of cytokine signalling-1 (SOCS-1) gene in pancreatic ductal neoplasms. Br J Cancer. 2003;89:338-43. (Pubitemid 36980626)
20. Ueki T, Toyota M, Sohn T, et al. Hypermethylation of multiple genes in pancreatic adenocarcinoma. Cancer Res. 2000;60:1835-9. (Pubitemid 30207640)
21. Esteller M, Sparks A, Toyota M, et al. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res. 2000;60:4366-71. (Pubitemid 32103613)
22. Ohtsubo K, Watanabe H, Yamaguchi Y, et al. Abnormalities of tumor suppressor gene p16 in pancreatic carcinoma: immunohistochemical and genetic findings compared with clinicopathological parameters. J Gastroenterol. 2003;38:663-71. (Pubitemid 36974980)
23. Sato N, Fukushima N, Maitra A, et al. Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. Cancer Res. 2003;63:3735-42. (Pubitemid 36793060)
24. Sato N, Parker AR, Fukushima N, et al. Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma. Oncogene. 2005;24:850-8. (Pubitemid 40216093)
25. Fukushima N, Walter KM, Uek T, et al. Diagnosing PCa using methylation specific PCR analysis of pancreatic juice. Cancer Biol Ther. 2003;2:78-83.
26. Matsubayashi H, Canto M, Sato N, et al. DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease. Cancer Res. 2006;66:1208-17. (Pubitemid 43165992)
27. Solcia E, Capella C, Klöppel G. Tumors of the pancreas. In: Atlas of Tumor Pathology, 3rd Series, Fascicte 20. Washington (DC): Armed Forces Institute of Pathology; 1997 p. 103-14.
28. Homma T, Harada H, Koizumi M. Diagnostic criteria for CP by the Japan Pancreas Society. Pancreas. 1997;15:14-5. (Pubitemid 27527354)
29. Jeronimo C, Henrique R, Hoque MO, et al. Quantitative promoter methylation profile of prostate cancer. Clin Cancer Res. 2004;10:8472-8. (Pubitemid 40053412)
30. Parsi MA, Li A, Li CP, et al. DNA methylation alterations in endoscopic retrograde cholangiopancreatography brush samples of patients with suspected pancreaticobiliary disease. Clin Gastroenterol Hepatol. 2008;6:1270-8.
31. Park JK, Ryu JK, Lee KH, et al. Quantitative analysis of NPTX2 hypermethylation is a promising molecular diagnostic marker for PCa. Pancreas. 2007;35:e9-15. (Pubitemid 47482531)
32. Hoque MO, Topaloglu O, Begum S, et al. Quantitative methylationspecific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects. J Clin Oncol. 2005;23:6569-75. (Pubitemid 46190250)
33. Fackler MJ, McVeigh M, Mehrotra J, et al. Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer. Cancer Res. 2004;64:4442-52. (Pubitemid 38856915)